Pharmaceutical companies rely heavily on vendors to ensure their product’s safety, quality,
and efficacy. The article "Vendor Selection" sheds light on the crucial role that vendor selection
plays in the pharmaceutical sector and provides insight into the most important aspects that
businesses ought to consider when selecting vendors. When choosing vendors for
manufacturing, testing, packaging, labeling, and distribution, the paper emphasizes that
pharmaceutical companies must adhere to stringent regulatory requirements and industry
standards. Product recalls, quality issues, regulatory violations, and damage to a company's
reputation are all possible outcomes if qualified and compliant vendors are not chosen. Vendor
qualification, risk assessments, audits, inspections, and quality agreements are all tools that
businesses can use to reduce these risks.
The article also discusses the difficulties and repercussions of effective vendor selection, such
as the requirement for ongoing monitoring, continuous improvement, and frequent
communication with vendors. To guarantee that vendors meet the requirements for quality and
compliance, businesses need to select vendors using a risk-based approach and create a robust vendor management program. To select the best vendors while minimizing quality and
compliance risks, businesses must consider various factors. A proactive, risk-based approach
and a strong commitment to quality and compliance are necessary for successful vendor
selection. By following accepted procedures and administrative necessities, drug organizations
can lay out with sellers that add to their prosperity and guarantee the security and viability of
their items.
Keywords: Vendor, qualification, selection, categories, pharmaceutical
Publication date: 01/07/2024
https://ijbpas.com/pdf/2024/July/MS_IJBPAS_2024_8177.pdf
Download PDF
https://doi.org/10.31032/IJBPAS/2024/13.7.8177
